Effects of Progressive Muscle Relaxation and Mindfulness Meditation in Patients With Chronic Obstructive Pulmonary Disease
1 other identifier
interventional
65
1 country
1
Brief Summary
Patients with COPD will be entered. Participants will be randomized to one of three study arms: Arm 1: meditation; Arm 2: relaxation; Arm 3: Control. Hypothesis: Progressive muscle relaxation and mindfulness meditation will decrease severity of dyspnea, fatigue and care dependency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2018
CompletedFirst Submitted
Initial submission to the registry
March 6, 2020
CompletedFirst Posted
Study publicly available on registry
March 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2020
CompletedMarch 10, 2020
March 1, 2020
1.9 years
March 6, 2020
March 9, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Change in dyspnea
Dyspnea will be measured by The Dyspnea-12 Scale. The range of total score was from 0 to 36, with higher scores demonstrating higher dyspnea level.
Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions
Change in fatigue
Quality of live will be measured by Asthma Fatigue Scale (CAFS). The CAFS scores is standardized to 0-100 in line with the following formula, (100 × (total score-minimum value to be obtained)/range), with higher scores indicating greater fatigue.
Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions
Change in care dependency
Quality of live will be measured by Care Dependency Scale (CDS). The sum of the scores changes from 17 to 85, with higher scores demonstrating lower dependence.
Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions
Other Outcomes (1)
Dyspnea
Baseline
Study Arms (3)
relaxation
EXPERIMENTALThe progressive muscle relaxation intervention, designed by Jacobson (1987), will be consist of sessions involving straining and relaxing all muscle groups from head to foot with deep breathing and last for 20 min. The patients will be asked to tense a very muscle group for 5 s and relax after counting up to 10 s while breathing out. In this way, facial, head, neck, shoulders, arms, chest, abdomen, legs, hips, feet and fingers muscles are stretched and relaxed on purpose for relaxing in patients with COPD.
mindfulness meditation
EXPERIMENTALThe research team closely will be following the mindfulness meditation intervention, developed by Kabat-Zinn, Lipworth, and Burney (1985), which is a part of the mindfulness-based stress reduction program. Mindfulness meditation is including interventions such as yoga, body scan, walking meditation, and sitting meditations. In the present study, the researchers will prefer sitting meditation. In this context, the second co-author will want patients to sit up in the chair in an upright and comfortable position. The patients will focus on deep breathing and felled the breath flowing throughout their body during the interventions that will last for 20 min in each session.
Control
NO INTERVENTIONPatients will continue to receive standard nursing care and no further intervention will be made during the research.
Interventions
three arms: mindfullness and relaxation
Eligibility Criteria
You may qualify if:
- older than 40 years
- diagnosed with stage III-IV COPD
- had at least primary school degree
- had no cognitive dysfunction, or communication problems
- were residing in Ankara.
You may not qualify if:
- history of cognitive dysfunction, or communication problems
- illiteracy
- applying any complementary and integrative approach during the study
- participating in a pulmonary rehabilitation program during the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Altindag, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Single (Outcomes Assessor)
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research assistant
Study Record Dates
First Submitted
March 6, 2020
First Posted
March 10, 2020
Study Start
April 20, 2018
Primary Completion
March 20, 2020
Study Completion
April 20, 2020
Last Updated
March 10, 2020
Record last verified: 2020-03